-
Regional comparison of efficacy and safety for vilobelimab in critically ill, invasively mechanically ventilated COVID-19 patients
Lim, E. H. T., van de Beek, D., de Bruin, S., Rückinger, S., Thielert, C. & PANAMO study group, 17 Apr 2025, In: BMJ Open Respiratory Research. 12, 1, e002206.Research output: Contribution to journal › Article* › Academic › peer-review
-
Host Response Protein Biomarkers Indicative of Persistent Acute Kidney Injury in Critically Ill COVID-19 Patients
Steenvoorden, T. S., de Kruijf, K. C., Appelman, B., Moggre, B., Bos, L. D. J., Vlaar, A. P. J., Douma, R. A., Uhel, F., Kers, J., Oppelaar, J. J., van Vught, L. A., Beudel, M., Elbers, P. W. G., Joost Wiersinga, W., van der Poll, T., Vogt, L., the Amsterdam UMC COVID-19 biobank study group & the CovidPredict Study Group, 13 Mar 2025, In: Critical care explorations. 7, 3Research output: Contribution to journal › Article* › Academic › peer-review
-
Plasma transfusion in the intensive care unit
InPUT Study Group, 18 Dec 2024, (E-pub ahead of print) In: Transfusion.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
